20314 ⎘
Medicinal preparations containing organic active ingredients; Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
Heteroarylsulfonyl Compounds As USP18 Inhibitors
#2SELECTIVE ESTROGEN RECEPTOR MODULATOR FOR TREATMENT OF PANCREATIC CANCER
#3NOVEL AMORPHOUS ACTIVE PHARMACEUTICAL INGREDIENTS
#41H-CYCLOPENTA[B]BENZOFURAN DERIVATIVES FOR THE PREVENTION AND TREATMENT OF VIRUS DISEASES
#5ABAD INHIBITOR COMPOUNDS
#6METHODS FOR TREATING CANCER
#7ORAL COMPOSITIONS COMPRISING LP(A) INHIBITOR COMPOUNDS
#8HISTONE DEACETYLASE INHIBITOR AND USES THEREOF
#9METHODS AND COMPOSITIONS FOR TREATMENT OF ENDOTHELIN B RECEPTOR EXPRESSING TUMORS
#10PAPD5 INHIBITORS AND METHODS OF USE THEREOF
#11INHIBITORS OF GLUCOSYLCERAMIDE SYNTHASE
#12SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS
#13LYMPH DIRECTING PRODRUGS
#14PYRIMIDINE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR PREVENTING OR TREATING CANCERS INCLUDING THE SAME
#15BENZOFURAN DERIVATIVES AS SIK INHIBITORS AND THE USE THEREOF
#16COMPOSITIONS, FORMULATIONS, AND METHODS FOR TREATMENT OF INFLAMMATORY CONDITIONS
#17TREATMENT OF DIABETIC RETINOPATHY USING ENDOTHELIN RECEPTOR ANTAGONISTS
#18Pharmaceutical Combinations For The Treatment Of Cancer
#19COMPOUNDS AND COMPOSITIONS USEFUL FOR TREATMENT OF PROLIFERATIVE DISEASE OR DISORDER
#20NOVEL SUBSTITUTED BENZOTHIOPHENE-6-CARBOXYLIC ACID DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THERAPEUTIC USES THEREOF
#21HETEROCYCLIC COMPOUND, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL USE THEREOF
#22APOL1 INHIBITORS AND METHODS OF USE
#23HETEROCYCLIC RING-SUBSTITUTED AROMATIC COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF
#24READY-TO-USE, TERMINALLY STERILE PACKAGING FOR SURGICAL ANTISEPTIC AND METHOD OF USE
#25J-Tp Protection
#26INHIBITION OF GLIAL CELL ACTIVATION
#275-METHOXY-N,N-DIMETHYLTRYPTAMINE ANALOGS, THEIR SYNTHESIS, AND METHODS FOR TREATMENT OF NEUROLOGICAL, PSYCHIATRIC, AND SUBSTANCE USE DISORDERS
#28XPG INHIBITOR COMPOUNDS AND THE USE THEREOF IN THE TREATMENT OF CANCER
#29N-(3-(BENZO[B]THIOPHENE-2-CARBOXAMIDO)-PHENYL)-2,3-DIHYDROBENZO[B][1,4]DIOXINE-6-CARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS LACTATE/ATP PRODUCTION INHIBITORS FOR THE TREATMENT OF CANCER
#30HETEROARYL CARBOXAMIDE AND RELATED GPR84 ANTAGONISTS AND USES THEREOF
#31Biphenyl and Phenylpyridine Compounds
#32CELL-PERMEANT COVALENT INHIBITORS OF VIRAL CYSTEINE PROTEASES
#33Compounds for the Treatment of Neurodegenerative Diseases
#34ESKETAMINE FOR USE IN TREATING MAJOR DEPRESSIVE DISORDER
#35Prostaglandin E synthase 3 (PTGES3) Inhibiting Compounds
#36DIHYDROMYRICETIN (DHM) DERIVATIVE AND PREPARATION METHOD AND USE THEREOF
#37COMPOUND CONTAINING SULFAMIDE STRUCTURE, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF, AND PHARMACEUTICAL COMPOSITION AND APPLICATION
#38PYRROLES AND IMIDAZOLES AS BET PROTEIN INHIBITORS
#39NLRP3 INHIBITORS
#40ARYL-ANILINE AND HETEROARYL-ANILINE COMPOUNDS FOR TREATMENT OF SKIN CANCERS
#41TOPICAL OCULAR DELIVERY OF CROMAKALIM
#42METHODS OF TREATING OR PREVENTING OVERACTIVE BLADDER SYNDROME
#43VLA4 INHIBITORS AND USES THEREOF
#44NEXT GENERATION DIPROVOCIMS THAT ACTIVATE THE INNATE AND ADAPTIVE IMMUNE RESPONSE
#45Compounds and Pharmaceutical Compositions Useful for Managing Sickle Cell Disease and Conditions Related Thereto
#46PROCESSES FOR PREPARING SOLID STATE FORMS
#47COMBINED USE OF M1 MUSCARINIC RECEPTOR AGONISTS AND M3 MUSCARINIC RECEPTOR ANTAGONISTS TO TREAT CANCER
#48METHODS OF TREATING FOCAL SEGMENTAL GLOMERULOSCLEROSIS WITH ATRASENTAN
#49LYMPH DIRECTING PRODRUGS
#50NEW DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS
#51ANTAGONISTS OF GPR39 PROTEIN
#52PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF CANCER
#53PHARMACEUTICAL COMPOSITION COMPRISING ELIGLUSTAT
#54CHROMEN-2-ONE MODULATORS OF POLRMT
#554-PHENYL-2-PYRROLIDINONES AND METHODS OF USING THEREOF
#56USE OF TOLL-LIKE RECEPTOR 2 (TLR-2) AGONIST FOR MODULATING HUMAN IMMUNE RESPONSE
#57MODULATION OF BACE1 AS A THERAPY FOR SPINOCEREBELLAR ATAXIA
#58SALT OF ENDOTHELIN A (ETA) RECEPTOR ANTAGONIST COMPOUND, AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF
#59NEW DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS
#60NUCLEIC ACID BINDERS
#61TREATMENT FOR DIABETES IN PATIENTS INAPPROPRIATE FOR METFORMIN THERAPY
#62ESKETAMINE FOR USE IN TREATING MAJOR DEPRESSIVE DISORDER
#63Ether-Linked Antiviral Compounds
#64SULCARDINE ADMINISTRATION FOR TREATMENT OF ACUTE ATRIAL FIBRILLATION
#65NOVEL TREATMENT
#66COMPOSITION FOR TREATING OR PREVENTING CANCER
#67MODULATORS OF INTRACELLULAR CHLORIDE CONCENTRATION FOR USE IN THE TREATMENT OF COGNITIVE DECLINE
#68COMPOSITIONS AND METHODS FOR NEUROABLATION
#69METHODS OF IMPROVING RENAL FUNCTION
#70COMBINATION THERAPIES COMPRISING QTX125
#71SMALL MOLECULE ANTAGONISTS OF PF4
#72ORAL COMPLEMENT FACTOR D INHIBITORS
#73PKC INHIBITORS FOR THE TREATMENT OF SEPTIC CHOLESTASIS WITH CTM TARGETING
#74PYRROLES AND IMIDAZOLES AS BET PROTEIN INHIBITORS
#75NOVEL SUBSTITUTED 4-AMINO-4-OXO-BUT-2-ENYL DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THERAPEUTIC USES THEREOF
#76NOVEL SUBSTITUTED FLUORINATED N-PROPYL-PYRROLIDINE COMPOUNDS, PROCESSES FOR THEIR PREPARATION AND THERAPEUTIC USES THEREOF
#772,3-DIHYDROBENZO[B][1,4]DIOXIN-6-YL CONTAINING COMPOUNDS USEFUL AS IMMUNOMODULATORS
#78Pharmaceutical Combinations For The Treatment Of Cancer
#79T-TYPE CALCIUM CHANNEL MODULATORS COMPRISING AN AZASPIRONONANE CORE AND METHODS OF USE THEREOF
#80LYMPH DIRECTING PRODRUGS
#812-[(2-OXO-4-PHENYL-2H-CHROMEN-7-YL)OXY] PROPANAMIDO DERIVATIVES
#82NOVEL RAS INHIBITORS
#83COMPOUNDS FOR THE TREATMENT OF CANCERS ASSOCIATED WITH HUMAN PAPILLOMAVIRUS
#84Biphenyl and Phenylpyridine Compounds
#85METHODS AND SYSTEMS FOR AUTOMATED NEUROCOGNITIVE TRAINING TO EXTEND RELIEF OF TREATMENT-RESISTANT MENTAL DISORDERS
#86COMPOSITIONS AND METHODS FOR THE TREATMENT OF GLIOBLASTOMA WITH A DUAL TARGETING ANTI-TUMOR COMPOSITION
#87METHOD OF TREATING WET AGE-RELATED MACULAR DEGENERATION
#88Substituted 2-(pyrrolidine-3-yl)acetic acid derivative, preparation method and use thereof
#89INHIBITORS OF RNA HELICASE DHX9 AND USES THEREOF
#90ANTIBACTERIAL AGENTS
#91INHIBITOR OF INTERACTION BETWEEN YAP/TAZ AND TEAD, PREPARATION THEREOF, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF
#92PSYCHEDELIC COMPOUNDS AND THEIR THERAPEUTIC USES
#93PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT MEDIATED DISORDERS
#94COMPOUND SERVING AS MASP-2 INHIBITOR, PHARMACEUTICAL COMPOSITION, PREPARATION METHOD THEREFOR, AND USE THEREOF
#95(R)-2-[(2H-1,3-BENZODIOXOL-5-YL)METHYL]PYRROLIDINE AND PROCESSES FOR PREPARATION, COMPOSITIONS AND USES THEREOF
#96COMPOUND CONTAINING BIS(AZANYLYLIDENE) SULFONYL STRUCTURE AND USE THEREOF IN MEDICINE
#97MODULATORS OF THE INTEGRATED STRESS PATHWAY
#98SULCARDINE SALTS
#99FUSED HETEROCYCLIC COMPOUNDS AS PI3KALPHA INHIBITORS
#100SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS
#101P53 MODULATORS
#102METHODS OF IMPROVING RENAL FUNCTION
#103ROCAGLATE DERIVATIVES AND USES THEREOF
#104METHODS OF USE OF PHENOXYPROPYLAMINE COMPOUNDS TO TREAT DEPRESSION
#105TOPICAL OCULAR DELIVERY OF CROMAKALIM
#106TOPICAL OCULAR DELIVERY OF CROMAKALIM
#107Active Metabolites of Kinesin Spindle Protein Inhibitor Conjugates
#108COMBINATION THERAPY FOR TREATING ABNORMAL CELL GROWTH
#109TREATMENT OF DIABETIC RETINOPATHY USING ENDOTHELIN RECEPTOR ANTAGONISTS
#110SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS
#111SREBP-1 INHIBITOR AND PHARMACEUTICAL COMPOSITION FOR TREATING HYPERTRIGLYCERIDEMIA
#112NITROPHENYL-ACRYLAMIDES AND USES THEREOF
#113DIPHENOLIC COMPOUNDS AND PREPARATION METHODS THEREOF
#114METHODS OF TREATING OR PREVENTING PRETERM LABOR
#115BENZOTHIAZOLE, BENZOISOXAZOLE, AND BENZODIOXOLE ANALOGS AS RXFP1 RECEPTOR AGONISTS
#116Chemical Activators of Nicotinamide Mononucleotide adenylyltransferase 2 (NMNAT2) and Uses Thereof
#117A SYNERGISTIC PHARMACEUTICAL COMPOSITION AND ITS ANTIVIRAL USE
#118SMALL MOLECULE INHIBITORS OF PR3 AND HNE AND USES THEREOF
#119Glucose and Lipid Metabolism Regulating Agents, Pharmaceutical Compositions Comprising the Same, and Treatment Methods
#120Deuterated Antiviral Compounds
#121FERROCHELATASE INHIBITORS AND METHODS OF USE
#122PHARMACEUTICAL COMPOUNDS AND METHODS OF MAKING AND USING THE SAME
#123SUBSTITUTED PHENYLPROPIONIC ACID DERIVATIVE AND USE THEREOF
#124COMPOUNDS AND THEIR USES AS GPR183 INHIBITORS
#125COMPOUNDS AND METHODS FOR MODULATING RAS-PI3K
#126PROCESS FOR PREPARING A BENZOATE SALT OF A 1-(3-AMINOPYRROLIDINE-1-CARBONYL)-3,4-DIPHENYLBENZENE COMPOUND
#127COMPOUNDS AND METHODS FOR TREATING CORONA VIRUSES
#128PHARMACEUTICAL COMPOSITION AND A PROCESS TO PREPARE THE SAME
#129CRYSTALLINE FORMS OF BIARYL YAP/TAZ-TEAD PROTEIN-PROTEIN INTERACTION INHIBITORS
#130NEW N-PHENYLPYRROLAMIDE INHIBITORS OF DNA GYRASE AND TOPOISOMERASE IV WITH ANTIBACTERIAL ACTIVITY
#131PHARMACEUTICALLY ACCEPTABLE SALT OF ELIGLUSTAT AND CRYSTAL FORM THEREOF
#132COMPOUNDS FOR THE TREATMENT OF SARS
#133CYANO COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF
#134PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF CANCER
#135NOVEL INHIBITOR OF HYPE-MEDIATED AMPYLATION
#136BIARYL DERIVATIVES AS YAP/TAZ-TEAD PROTEIN-PROTEIN INTERACTION INHIBITORS
#137ANTICHOLINERGIC COMPOUNDS FOR USE IN TREATING NEUROMUSCULAR DISORDERS
#138SUBSTITUTED TETRAHYDROFURAN-2-CARBOXAMIDES AS MODULATORS OF SODIUM CHANNELS
#139AROMATIC COMPOUND, PHARMACEUTICAL COMPOSITION, AND APPLICATION THEREOF
#140ALLOSTERIC MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS
#141HYDROXY AND ALKOXY COUMARINS AS MODULATORS OF POLRMT
#142ARYL HETEROCYCLIC COMPOUNDS AS Kv1.3 POTASSIUM SHAKER CHANNEL BLOCKERS
#143TREATMENT OF HFPEF IN POST-MENOPAUSAL WOMEN WITH AN SGC STIMULATOR
#144USE OF NOX INHIBITORS FOR TREATMENT OF CANCER
#145INTRANASAL DESMOPRESSIN ADMINISTRATION
#146COMBINATIONAL THERAPY OF LSD1 INHIBITORS WITH P21 ACTIVATORS IN THE TREATMENT OF CANCER
#147MICRORNA-REGULATED BIOMARKERS AND DRUG TARGETS FOR IMPROVING DIAGNOSIS AND TREATMENT OF LUNG OR BREAST CANCER
#148D3 DOPAMINE RECEPTOR-SELECTIVE NEGATIVE ALLOSTERIC MODULATORS
#149RADIOLABELED COMPOSITIONS AND METHODS OF USE THEREOF
#150METHODS AND COMPOSITIONS FOR POTENTIATING THE ACTION OF OPIOID ANALGESICS USING IBOGA ALKALOIDS
#151(R)-2-[(2H-1,3-BENZODIOXOL-5-YL)METHYL]PYRROLIDINE AND PROCESSES FOR PREPARATION, COMPOSITIONS AND USES THEREOF
#152METHOD AND COMPOSITIONS FOR THE TREATMENT AND DETECTION OF ENDOTHELIN-1 RELATED KIDNEY DISEASES
#153SULFONAMIDE COMPOUNDS AND THE USE THEREOF IN THE TREATMENT OF CANCER
#154APOL1 INHIBITORS AND METHODS OF USE
#155MICROSPHERE FORMULATIONS AND METHODS OF PREPARATION THEREOF
#156SMALL MOLECULE INHIBITOR AGAINST NASOPHARYNGEAL CARCINOMA, PREPARATION METHOD AND APPLICATION THEREOF
#157CONFORMATIONALLY-CONSTRAINED INHIBITORS OF 3C OR 3C-LIKE PROTEASES
#158USE OF SOBETIROME AND PRODRUGS AND DERIVATIVES THEREOF FOR TREATING PITT-HOPKINS SYNDROME
#1593-PYRROLYLSULFONAMIDE COMPOUNDS AS GPR17 ANTAGONISTS
#160COMPOUNDS CONSTITUTING C20-MODIFIED SALINOMYCIN DERIVATIVES, A METHOD FOR OBTAINING THE SAME, A COMPOSITION CONTAINING THE SAME AND A USE OF SAID COMPOUNDS
#161ROS-RESPONSIVE CAPTOPRIL-CINNAMALDEHYDE PRODRUGS AND COMPOSITIONS AND METHODS THEREOF
#162COMPOUND AND METHOD FOR TREATING CHEMOTHERAPY-RELATED GASTROINTESTINAL SIDE EFFECTS
#163COMPOUNDS FOR THE TREATMENT OF SARS
#164COMPOSITIONS AND METHODS FOR EXTENDED RELEASE CROMAKALIM THERAPY
#165SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER
#166CHARGED ION CHANNEL BLOCKERS AND METHODS FOR USE
#167COMBINATION THERAPIES USING IMMUNO-DASH INHIBITORS AND PGE2 ANTAGONISTS
#168METHODS OF TREATING INTERSTITIAL CYSTITIS/BLADDER PAIN SYNDROME
#169Processes for preparing solid state forms
#170METHODS OF TREATING BACTERIAL INFECTIONS
#171METHODS OF TREATING BACTERIAL INFECTIONS
#172SYNTHESIS AND NOVEL SALT FORMS OF (R)-5-((E)-2-(PYRROLIDIN-3-YLVINYL)PYRIMIDINE
#173TEAD INHIBITORS
#1742-(3-ETHYNYLBENZYL)-SUBSTITUTED HETEROCYCLE DERIVATIVES AND RELATED USES
#175COMBINATION THERAPY FOR PULMONARY HYPERTENSION
#176COMPOSITIONS AND METHODS FOR TREATMENT OF CERVICAL AND OVARIAN CANCER
#177ANTIVIRAL COMPOUNDS, METHODS FOR THE MANUFACTURING OF COMPOUNDS, ANTIVIRAL PHARMACEUTICAL COMPOSITION, USE OF THE COMPOUNDS AND METHOD FOR THE ORAL TREATMENT OF CORONAVIRUS INFECTION AND RELATED DISEASES THEREOF
#178COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATING TYPE 2 DIABETES AND DEMENTIA
#179SPIRO-CONTAINING DERIVATIVE, AND PREPARATION METHOD THEREFOR AND USE THEREOF
#180TREATMENT OF GLAUCOMA USING ENDOTHELIN RECEPTOR ANTAGONISTS
#181COMPOSITIONS COMPRISING LACTATE DEHYDROGENASE-A INHIBITORS AND METHODS OF PRODUCTION AND USE THEREOF
#182TELOMERASE ACTIVATING COMPOUNDS FOR USE IN FERTILITY AND RELATED APPLICATIONS
#183RUNX1 Inhibition for Treatment of Proliferative Vitreoretinopathy and Conditions Associated with Epithelial to Mesenchymal Transition
#184TREATMENT OF INFLAMMATORY DISEASES
#185PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF MELANOMA
#186CANCER THERAPEUTIC AGENT
#187TLR2 MODULATOR COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
#188COMPOSITIONS AND METHODS FOR THE TREATMENT OF PLASMODIUM FALCIPARUM MALARIA
#189TUMESCENT SOLUTION WITH B VITAMINS
#190HBV INHIBITOR AND ITS USE
#191SULCARDINE ADMINISTRATION FOR TREATMENT OF ACUTE ATRIAL FIBRILLATION
#192METHODS OF IMPROVING RENAL FUNCTION
#193METHODS AND COMPOSITIONS FOR TREATMENT OF DISORDERS AMELIORATED BY MUSCARINIC RECEPTOR ACTIVATION
#194PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING VIRAL INFECTIONS CONTAINING PIPERLONGUMINE-BASED COMPOUND AS ACTIVE INGREDIENT
#195Compositions having improved bioavailability of therapeutics
#196DRUGS, THERAPEUTIC COMBINATIONS AND METHODS FOR PREVENTING VIRAL AND MICROBIAL INFECTIONS AND THEIR SEQUELAE
#197METHODS FOR OPTIMIZING CFTR-MODULATOR THERAPY
#198CHRM3 AS A MARKER AND TARGET FOR CANCER THERAPY
#199SULCARDINE ADMINISTRATION FOR TREATMENT OF ACUTE ATRIAL FIBRILLATION 94919.0739.717301US
#200(R)-2-[(2H-1,3-benzodioxol-5-yl)methyl]pyrrolidine and processes for preparation, compositions and uses thereof
#201METHODS OF TREATING A CORONAVIRUS INFECTION
#202TREATMENT OF KRAS MUTANT CANCERS
#203NOVEL AMORPHOUS ACTIVE PHARMACEUTICAL INGREDIENTS
#204METHODS FOR TREATMENT OF VIRAL INFECTIONS
#205PROSTAGLANDIN RECEPTOR AGONISTS FOR USE IN THE TREATMENT OF A CORONAVIRUS INFECTION SUCH AS COVID-19
#206INHIBITION OF CASPASE PATHWAY AS A TREATMENT FOR LYSOSOMAL STORAGE DISORDERS
#207PYRROLE COMPOUNDS
#208DASH INHIBITORS, AND USES RELATED THERETO
#209Substituted benzothiophene analogs as selective estrogen receptor degraders
#210TREATMENTS OF CORONAVIRUS INFECTIONS, CYTOKINE RELEASE SYNDROME, CYTOKINE STORM SYNDROME, OR DISEASES ASSOCIATED WITH EXCESSIVE ACTIVATION OF INFLAMMASOMES BY THE USE OF INHIBITORS OF INFLAMMATORY CASPASES
#211COMPOSITIONS AND METHODS FOR TREATING CANCER
#212Methods of improving renal function
#213METHODS FOR TREATING COVID-19
#214Methods of improving renal function
#215METHODS OF REDUCING DISEASE FLARES
#216Treatment for Diseases Caused by RNA Viruses
#217MICROBIAL STRAINS AND ANTIBIOTICS
#218PH-RESPONSIVE LIPIDOID NANOPARTICLES FOR INTRACELLULAR MRNA DELIVERY
#219METHODS AND COMPOSITIONS FOR HYPOTENSIVE RESUSCITATION
#220TREATMENT OF ER-NEGATIVE BREAST CANCER WITH AN PDGF-CC INHIBITOR AND AN ANTI-ESTROGEN
#221SYNTHESIS AND NOVEL SALT FORMS OF (R)-5-((E)-2-PYRROLIDIN-3-YLVINYL)PYRIMIDINE
#222COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONS
#223METHODS OF TREATING DIABETIC KIDNEY DISEASE
#224COMBINATION OF A BTK INHIBITOR AND AN INHIBITOR OF CDK9 TO TREAT CANCER
#225COMPOSITIONS FOR PREVENTING OR TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASES (COPD)
#226COMPOUNDS FOR THE PREVENTION, TREATMENT AND DIAGNOSIS OF THROMBI
#227MACROGOL 15 HYDROXYSTEARATE FORMULATIONS
#228COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING RADIATION-INDUCED BYSTANDER EFFECTS CAUSED BY RADIATION OR RADIOTHERAPY
#229METHODS AND FORMULATIONS FOR TREATING AND PREVENTING LONG HAUL CORONAVIRUS (LONG COVID) SYMPTOMS AND SEQUELAE
#230COMPOUNDS FOR USE IN THE TREATMENT OF ACUTE INTERMITTENT PORPHYRIA
#231Method for Predicting Effectiveness of Angiogenesis Inhibitor
#232Treatment for Diseases Caused By RNA Viruses
#233PHOTOSYNTHETICALLY CONTROLLED SPIRULINA EXTRACTS FOR TREATING THE CYTOKINE STORM SYNDROME
#234USE OF COMPOUNDS FOR TREATING VIRAL INFECTIONS
#235INHIBITORS OF GLUCOSYLCERAMIDE SYNTHASE
#236SMALL-MOLECULE INHIBITOR TARGETING EB VIRUS NUCLEAR ANTIGEN PROTEIN, PREPARATION METHOD AND USE THEREOF
#237METHOD FOR THE TREATMENT NLRP3-ASSOCIATED DISEASES
#238Tissue factor-targeted antibody-drug conjugate
#239PHARMACEUTICAL USE OF KETOAMIDE-BASED COMPOUND
#240USE OF TOLL-LIKE RECEPTOR 2 (TLR-2) AGONIST FOR MODULATING HUMAN IMMUNE RESPONSE
#241METHODS OF IMPROVING RENAL FUNCTION
#242COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASES
#243AGENTS FOR USE IN THE TREATMENT OF TISSUE DAMAGE
#244POLYMER DERIVATIVES HAVING PARTICULAR ATOM ARRANGEMENTS
#245STABLE COMPOSITIONS OF FUNCTIONAL INGREDIENTS AND METHODS OF MAKING THE SAME
#246TREATMENT OF ADDICTION AND IMPULSE-CONTROL DISORDERS USING PDE7 INHIBITORS
#247HEPATITIS B CAPSID ASSEMBLY MODULATORS
#248MATERIALS AND METHODS FOR THE TREATMENT OF GAUCHER DISEASE
#249BIOMARKERS FOR OXYTOCIN RECEPTOR ANTAGONIST THERAPY
#250Therapeutics for the treatment of glaucoma
#251COMPOSITIONS AND METHODS OF TREATING CARDIAC HYPERTROPHY AND HEART FAILURE
#252SUBSTITUTED HETEROCYCLICS WITH THERAPEUTIC ACTIVITY IN HIV
#253ARYL AND HETEROARYL COMPOUNDS, AND THERAPEUTIC USES THEREOF IN CONDITIONS ASSOCIATED WITH THE ALTERATION OF THE ACTIVITY OF GALACTOCEREBROSIDASE
#254TLR2 modulator compounds, pharmaceutical compositions and uses thereof
#255Difluorolactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions
#256TREATMENT FOR DISEASES CAUSED BY RNA VIRUSES
#257Antibody drug conjugates with enzymatically cleavable groups
#258THERAPEUTIC COMPOSITIONS AND METHODS FOR PREVENTION AND TREATMENT OF DIASTOLIC DYSFUNCTION
#2591-AMINOSULFONYL-2-CARBOXYPYRROLE DERIVATIVES AS METALLO-BETA-LACTAMASE INHIBITORS
#260INHALED STATINS AS BRONCHODILATORS TO IMPROVE LUNG FUNCTION IN RESPIRATORY DISEASES
#261ARYL-ANILINE AND HETEROARYL-ANILINE COMPOUNDS FOR TREATMENT OF BIRTHMARKS
#2624,9-dioxo-4,9-dihydronaphtho[2,3-B]furan-3-carboxamide derivatives and uses thereof for treating proliferative diseases and infectious diseases
#263PYRIMIDINE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR PREVENTING OR TREATING CANCERS INCLUDING THE SAME
#264Oral eliglustat transmucosal delivery system
#265Compositions comprising extract for mammalian consumption
#266COMPOUNDS FOR THE TREATMENT OF PARAMYXOVIRUS VIRAL INFECTIONS
#267COMPOUNDS
#268Methods for treating COVID-19
#269Anticancer compounds
#270PROSTAGLANDIN E2 (PGE2) EP4 RECEPTOR ANTAGONISTS
#271METHOD FOR TREATMENT OF PANCREATITIS
#272INHIBITORS OF HEPATITIS C VIRUS REPLICATION
#273ENDOCANNABINOID SYSTEM-TARGETING PRODRUGS AND THERAPEUTIC USES THEREOF
#274Bicyclic amide compounds and methods of use thereof
#275TREATMENT FOR DIABETES IN PATIENTS INAPPROPRIATE FOR METFORMIN THERAPY
#276NOVEL SUBSTITUTED SULFOXIMINE DERIVATIVES
#277SMALL MOLECULE INHIBITORS FOR TREATING CANCER IN A SUBJECT HAVING TUMORS WITH HIGH INTERSTITIAL PRESSURE
#278Compositions Having Improved Bioavailability of Therapeutics
#279METHODS OF REDUCING DISEASE FLARES
#280INHIBITING MESANGIAL CELL ACTIVATION
#281NOVEL ANTIVIRAL COMPOSITIONS FOR TREATING THE FLU
#282NOVEL ENTERIC COMBINATION THERAPY
#283Methods of improving renal function
#284METHODS OF TREATING KIDNEY DISEASES
#285Sulcardine administration for treatment of acute atrial fibrillation
#286KCNT1 INHIBITORS AND METHODS OF USE
#287PHARMACEUTICAL FORMULATIONS COMPRISING SODIUM PALMITOYL-L-PROLYL-L-PROLYLGLYCYL-L-TYROSINATE AND METHODS FOR PREPARING THE SAME
#288TREATMENT OF UROTHELIAL AND KIDNEY CANCERS BY USE OF ENDOTHELIN B RECEPTOR ANTAGONISTS
#289METHOD AND COMPOSITIONS FOR THE TREATMENT AND DETECTION OF ENDOTHELIN-1 RELATED KIDNEY DISEASES
#290METHODS AND COMPOSITIONS FOR TREATMENT OF ENDOTHELIN B RECEPTOR EXPRESSING TUMORS
#291COMPOSITIONS AND METHODS FOR MODULATING VIRAL INFECTIONS BY REGULATING GLUCOSYLCERAMIDES
#292Treatment of glaucoma using endothelin receptor antagonists
#293DOSING REGIMENS FOR ORAL COMPLEMENT FACTOR D INHIBITORS
#294TREATMENT OF OCULAR DISEASES USING ENDOTHELIN RECEPTOR ANTAGONISTS
#295METHODS AND COMPOSITIONS FOR TREATING ANDROGEN RECEPTOR DEFICIENT, ANDROGEN RECEPTOR LOW, AND CASTRATION-RESISTANT PROSTATE CANCERS
#296COMPOSITIONS AND METHODS FOR MONITORING, DIAGNOSIS, DETECTION AND TREATMENT OF CANCER
#297Enteric combination therapy
#298ACYL SULFONAMIDES FOR TREATING CANCER
#299COMPOSITIONS AND METHODS COMPRISING ENDOTHELIN A RECEPTOR ANTAGONISTS AND ANDROGEN THERAPIES
#300Methods, agents, and compositions for the treatment of acute myeloid leukemia